Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176K Buy
137,644
+38,570
+39% +$54.3K 0.04% 708
2026
Q1
$148K Sell
99,074
-52,835
-35% -$80.3K 0.04% 678
2025
Q4
$201K Buy
+151,909
New +$191K 0.08% 556
2024
Q4
Sell
-49,263
Closed -$224K 814
2024
Q3
$224K Buy
+49,263
New +$224K 0.13% 398
2024
Q1
Sell
-59,926
Closed -$126K 1548
2023
Q4
$126K Buy
+59,926
New +$117K 0.12% 263

Other funds holding GERN

EntryPoint Capital's GERN Position: Q2 2026 in Review

EntryPoint Capital increased its Geron (GERN) stake by 39% in Q2 2026, buying an estimated $54.3K and bringing the position to 137,644 shares worth $176K. The position accounts for 0.04% of the portfolio, ranked #708.

EntryPoint Capital first reported a position in GERN in Q4 2023 and has held it in 5 quarters since. The position peaked at $224K in Q3 2024. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • EntryPoint Capital held 137,644 shares of Geron worth $176K as of Q2 2026.
  • EntryPoint Capital bought 38,570 Geron shares in Q2 2026, an estimated $54.3K.
  • Geron made up 0.04% of EntryPoint Capital's portfolio in Q2 2026, its #708 holding.
  • EntryPoint Capital first reported a position in Geron in Q4 2023 and has held it in 5 quarters since.
  • EntryPoint Capital's Geron position peaked at $224K in Q3 2024.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.